Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-11-24

Clinical Trial Update: Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Xingnaojing for convulsive diseases, sponsored by Shenzhen Children's Hospital; current status and results are not disc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xingnaojing

Snippet

Sponsor: Shenzhen Children's Hospital | Conditions: Convulsive Diseases | Phase 4 | Status: UNKNOWN